VANCE WEALTH, INC. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANCE WEALTH, INC. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$73,427
-25.5%
39,2660.0%0.03%
-24.4%
Q2 2023$98,558
+43.4%
39,2660.0%0.04%
+21.6%
Q1 2023$68,716
+21.6%
39,266
+195.3%
0.04%
+5.7%
Q4 2022$56,521
+253.3%
13,2990.0%0.04%
+191.7%
Q3 2022$16,000
+23.1%
13,2990.0%0.01%
+20.0%
Q2 2022$13,000
-60.6%
13,2990.0%0.01%
-76.2%
Q1 2022$33,0000.0%13,299
+8.1%
0.04%
+31.2%
Q4 2021$33,00012,2990.03%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders